Match each Hepatitis B (HBV) serologic and virologic profile to its corresponding clinical disease state.
- HBsAg (+), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 250,000 IU/mL, ALT = 150 U/LHBeAg-negative chronic active hepatitis B
- HBsAg (-), HBeAg (-), Anti-HBc IgM (+), Anti-HBs (-), HBV DNA = Undetectable, ALT = 400 U/LAcute hepatitis B window period
- HBsAg (+), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 450 IU/mL, ALT = 22 U/LInactive hepatitis B carrier state
- HBsAg (-), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (+), HBV DNA = Undetectable, ALT = 18 U/LResolved past hepatitis B infection
- HBsAg (+), HBeAg (+), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 5,000,000 IU/mL, ALT = 25 U/LChronic hepatitis B immune-tolerant phase
Answer
The serologic patterns map specifically to phases of HBV infection based on the interplay of surface/core antigens, antibodies, and viral replication activity indicated by HBV DNA and ALT levels.
Each profile uniquely identifies a specific phase of Hepatitis B infection. Accurate matching requires recognizing the virological significance of precore mutations (HBeAg-negative but highly active), the window period (isolated core IgM), immune tolerance (high DNA, low ALT), inactive carriage (low DNA, low ALT), and resolved infection (core IgG and surface antibodies).
Step-by-Step Solution
Key Concept
Hepatitis B Serology and Disease Phases